Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
White House fires all members of the U.S. Commission of Fine Arts, clearing the way for contested building plans.
Major U.S. stocks underperform despite overall market gains, highlighting sector-specific challenges.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
White House fires all members of the U.S. Commission of Fine Arts, clearing the way for contested building plans.
Major U.S. stocks underperform despite overall market gains, highlighting sector-specific challenges.